Claus Henrik Nielsen

Claus Henrik Nielsen

Professor


  1. 2016
  2. Published

    Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis: Impact on s-Infliximab and Antidrug-Antibodies. Results from the Danish Rheumatologic Biobank and the Danbio Registry

    Glintborg, B., Kringelbach, T. M., Høgdall, E. V. S., Sørensen, I. J., Jensen, D. V., Loft, A. G., Hendricks, O., Hansen, I. M. J., Linauskas, A., Kristensen, S., Lindegaard, H., Nordin, H., Bolstad, N., Warren, D., Gehin, J., Goll, G. L., Grøn, K. L., Eng, G., Enevold, C., Nielsen, C. H. & 2 others, Johansen, Julia Sidenius & Hetland, Merete Lund, 2016, In: Arthritis & Rheumatology. 68, S10, 4 p., 1997.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

ID: 927479